BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34360336)

  • 21. The Association of Ovarian Reserve with Exposure to Bisphenol A and Phthalate in Reproductive-aged Women.
    Park SY; Jeon JH; Jeong K; Chung HW; Lee H; Sung YA; Ye S; Ha EH
    J Korean Med Sci; 2021 Jan; 36(2):e1. PubMed ID: 33429469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
    Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
    Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is parental consanguinity associated with reduced ovarian reserve?
    Seher T; Thiering E; Al Azemi M; Heinrich J; Schmidt-Weber CB; Kivlahan C; Gutermuth J; Fatemi HM
    Reprod Biomed Online; 2015 Sep; 31(3):427-33. PubMed ID: 26206281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
    Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
    Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.
    Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M
    Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary phthalate metabolites in relation to serum anti-Müllerian hormone and inhibin B levels among women from a fertility center: a retrospective analysis.
    Du YY; Guo N; Wang YX; Hua X; Deng TR; Teng XM; Yao YC; Li YF
    Reprod Health; 2018 Feb; 15(1):33. PubMed ID: 29471860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis.
    Moslehi N; Shab-Bidar S; Ramezani Tehrani F; Mirmiran P; Azizi F
    Menopause; 2018 Sep; 25(9):1046-1055. PubMed ID: 29738413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian reserve in patients with ankylosing spondylitis.
    Yalçın Bahat P; Kadiroğulları P; Topbas Selcuki NF; Yücel B; Çakmak K; Üreyen Özdemir E
    Arch Gynecol Obstet; 2021 Jan; 303(1):189-193. PubMed ID: 33030584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
    Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
    Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-Term Impact of Laparoscopic Cystectomy on Ovarian Reserve Tests in Bilateral and Unilateral Endometriotic and Nonendometriotic Cysts.
    Salihoğlu KN; Dilbaz B; Cırık DA; Ozelci R; Ozkaya E; Mollamahmutoğlu L
    J Minim Invasive Gynecol; 2016; 23(5):719-25. PubMed ID: 26940401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Ovarian Reserve Assessment Model Based on Anti-Müllerian Hormone Levels, Follicle-Stimulating Hormone Levels, and Age: Retrospective Cohort Study.
    Xu H; Shi L; Feng G; Xiao Z; Chen L; Li R; Qiao J
    J Med Internet Res; 2020 Sep; 22(9):e19096. PubMed ID: 32667898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-reported history of comorbidities and markers of ovarian reserve among subfertile women.
    Mínguez-Alarcón L; Hammer KC; Williams PL; Souter I; Ford JB; Rexrode KM; Hauser R; Chavarro JE;
    J Assist Reprod Genet; 2022 Dec; 39(12):2719-2728. PubMed ID: 36322231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of blood groups with ovarian reserve and outcome of in vitro fertilization treatment.
    Awartani K; Al Ghabshi R; Al Shankiti H; Al Dossari M; Coskun S
    Ann Saudi Med; 2016; 36(2):116-20. PubMed ID: 27031784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between the antral follicle count, steroidogenesis, and secretion of follicle-stimulating hormone and anti-Müllerian hormone during follicular growth in cattle.
    Sakaguchi K; Yanagawa Y; Yoshioka K; Suda T; Katagiri S; Nagano M
    Reprod Biol Endocrinol; 2019 Nov; 17(1):88. PubMed ID: 31690325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L; Kristasashvili J
    Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
    Wang S; Pei L; Hu T; Jia M; Wang S
    Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.